BioNTech signs $425m flu vaccine deal with Pfizer
German biopharmaceutical company BioNTech has signed a research and development (R&D) agreement with Pfizer for the development of mRNA-based vaccines…
BioNTech
-
-
BioNTech and Genevant Sciences to develop rare disease drugs
German biopharmaceutical firm BioNTech has partnered with Genevant Sciences, a genetic disorder therapeutics maker, to develop mRNA therapy programmes, which…
